These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [A case of peritoneal metastasis of breast cancer successfully treated by multidisciplinary therapy with hyperthermia therapy]. Kusama M; Kimura K; Koyanagi Y; Shimizu T; Ebihara Y; Arima M; Murata A; Nakamura Y; Matsunaga T Gan To Kagaku Ryoho; 1994 Jun; 21(7):1067-70. PubMed ID: 8002623 [TBL] [Abstract][Full Text] [Related]
47. [Chemo-hyperthermic peritoneal perfusion for therapy of advanced gastric cancer with peritoneal dissemination]. Ikeguchi M; Kaibara N Nihon Rinsho; 2001 Apr; 59 Suppl 4():469-72. PubMed ID: 11424427 [No Abstract] [Full Text] [Related]
48. Neuroendocrine tumor of the rectum. Suyama K; Hayashi N; Shigaki H; Sato N; Hirashima K; Nagai Y; Hiyoshi Y; Sakamoto Y; Yoshida N; Toyama E; Watanabe M; Baba H Am J Surg; 2009 Sep; 198(3):e39-41. PubMed ID: 19716878 [TBL] [Abstract][Full Text] [Related]
49. Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? Baratti D; Pennacchioli E; Kusamura S; Fiore M; Balestra MR; Colombo C; Mingrone E; Gronchi A; Deraco M Ann Surg Oncol; 2010 Dec; 17(12):3220-8. PubMed ID: 20585874 [TBL] [Abstract][Full Text] [Related]
50. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival. Hagendoorn J; van Lammeren G; Boerma D; van der Beek E; Wiezer MJ; van Ramshorst B Eur J Surg Oncol; 2009 Aug; 35(8):833-7. PubMed ID: 19019619 [TBL] [Abstract][Full Text] [Related]
51. Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: role of heat shock proteins and dissecting effects of hyperthermia. Pelz JO; Vetterlein M; Grimmig T; Kerscher AG; Moll E; Lazariotou M; Matthes N; Faber M; Germer CT; Waaga-Gasser AM; Gasser M Ann Surg Oncol; 2013 Apr; 20(4):1105-13. PubMed ID: 23456378 [TBL] [Abstract][Full Text] [Related]
52. Problems of success and problems of failure: recurrent disease after cytoreductive surgery and intraperitoneal chemoperfusion. Levine EA Ann Surg Oncol; 2004 Apr; 11(4):351-3. PubMed ID: 15070590 [No Abstract] [Full Text] [Related]
53. Five reasons why cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy must be regarded as the new standard of care for diffuse malignant peritoneal mesotheliomia [corrected]. Sugarbaker PH Ann Surg Oncol; 2010 Jun; 17(6):1710-2; author reply 1713-4. PubMed ID: 20354799 [No Abstract] [Full Text] [Related]
54. [Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis caused by recurrent inflammatory myofibroblastic sarcoma: a case report and review of the literature]. Mátrai Z; Péley G; Kovács T; Rényi VF; Szívós E; Szabó E; Vereczkey I; Török K; Köves I Orv Hetil; 2006 Jan; 147(4):147-58. PubMed ID: 16515023 [TBL] [Abstract][Full Text] [Related]
55. [Perspectives in the treatment of peritoneal carcinosis]. Arnaud JP J Chir (Paris); 1997 Nov; 134(5-6):227-8. PubMed ID: 9772977 [No Abstract] [Full Text] [Related]
56. Cases in the Management of GEP-NETs: Combination Regimens. Braiteh F Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):11-3. PubMed ID: 27167993 [No Abstract] [Full Text] [Related]
58. Cytoreductive surgery plus intraperitoneal hyperthermic perfusion is an effective treatment for metastasized malignant mixed mesodermal tumours (MMMT)--report of six cases. Müller H; Nakchbandi V Eur J Surg Oncol; 2004 Jun; 30(5):573-7. PubMed ID: 15135489 [TBL] [Abstract][Full Text] [Related]
59. Indications and patient selection for cytoreductive surgery and perioperative intraperitoneal chemotherapy. González-Moreno S; Ortega-Pérez G; González-Bayón L J Surg Oncol; 2009 Sep; 100(4):287-92. PubMed ID: 19697424 [TBL] [Abstract][Full Text] [Related]